IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RHO Capital Partners Inc

Q2 2019 Holdings

Filed 2019-08-13 | 5 holdings | $144.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cara Therapeutics Inc(CARAEUR)COM140755109$70.3K3,268,05748.7%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$55.1K3,766,66738.3%
Livexlive Media IncCOM NEW53839L208$15.2K3,663,54010.5%
Mersana Therapeutics IncCOM59045L106$3.2K796,4582.2%
Senseonics Hldgs Inc(SENS1GBP)COM81727U105$326159,6010.2%